Published in Int J Hyperthermia on July 23, 2010
Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv (2011) 1.04
Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem (2014) 0.97
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet (2011) 0.90
Temperature of the magnetic nanoparticle microenvironment: estimation from relaxation times. Phys Med Biol (2014) 0.88
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines. Bioimpacts (2014) 0.86
Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia. Oncol Lett (2013) 0.85
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. Bioimpacts (2014) 0.85
Application of magnetic nanoparticles to gene delivery. Int J Mol Sci (2011) 0.85
Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches. Adv Funct Mater (2016) 0.84
Antitumor Activities of Metal Oxide Nanoparticles. Nanomaterials (Basel) (2015) 0.83
Polyethylene Glycol-Mediated Synthesis of Cubic Iron Oxide Nanoparticles with High Heating Power. Nanoscale Res Lett (2015) 0.82
Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia (2013) 0.82
Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging. Biomaterials (2014) 0.82
Focal therapy in prostate cancer: the current situation. Ecancermedicalscience (2014) 0.82
Computational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy. Nanomedicine (Lond) (2013) 0.81
Spectroscopic AC Susceptibility Imaging (sASI) of Magnetic Nanoparticles. J Magn Magn Mater (2015) 0.81
Synthesis of multifunctional magnetic nanoflakes for magnetic resonance imaging, hyperthermia, and targeting. ACS Appl Mater Interfaces (2014) 0.80
Assessment of the evolution of cancer treatment therapies. Cancers (Basel) (2011) 0.80
Nanoscale materials for hyperthermal theranostics. Nanoscale (2015) 0.77
Bench-to-bedside translation of magnetic nanoparticles. Nanomedicine (Lond) (2014) 0.77
Magnetic Nanoparticles with High Specific Absorption Rate at Low Alternating Magnetic Field. Nano Life (2015) 0.77
Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer. Int J Hyperthermia (2015) 0.77
Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues. Nanomedicine (Lond) (2014) 0.76
Recent advances in imaging-guided interventions for prostate cancers. Cancer Lett (2014) 0.76
Precise control over shape and size of iron oxide nanocrystals suitable for assembly into ordered particle arrays. Sci Technol Adv Mater (2014) 0.75
Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy. Int J Nanomedicine (2017) 0.75
Selective killing of cancer cells by nanoparticle-assisted ultrasound. J Nanobiotechnology (2016) 0.75
Radiolytic formation of Fe3O4 nanoparticles: influence of radiation dose on structure and magnetic properties. PLoS One (2014) 0.75
Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy. Int J Hyperthermia (2016) 0.75
Magnetic Heating of Fe-Co Ferrites: Experiments and Modeling. Nano Life (2016) 0.75
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging. Nanomaterials (Basel) (2016) 0.75
Magnetic hyperthermia enhance the treatment efficacy of peri-implant osteomyelitis. BMC Infect Dis (2017) 0.75
Theoretical Predictions for Spatially-Focused Heating of Magnetic Nanoparticles Guided by Magnetic Particle Imaging Field Gradients. J Magn Magn Mater (2016) 0.75
The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol (2002) 4.14
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol (2010) 2.66
Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia (2008) 2.32
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol (2006) 2.22
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol (2003) 2.04
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol (2010) 2.02
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol (2006) 2.00
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol (2005) 1.89
Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy. Onkologie (2005) 1.72
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J Exp Med (2008) 1.70
Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures. Int J Hyperthermia (2006) 1.50
CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys (2004) 1.38
Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer (2006) 1.28
Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys (2004) 1.26
Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate (2006) 1.11
Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis (2002) 1.10
A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys (2005) 1.08
Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. J Endourol (2004) 1.06
Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol (2004) 1.06
Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (2010) 1.03
Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging (2005) 1.01
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging (2004) 1.01
Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.99
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate (2005) 0.98
SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11. Oncogene (2002) 0.98
Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol (2008) 0.97
Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys (2007) 0.97
Non-invasive magnetic resonance thermography during regional hyperthermia. Int J Hyperthermia (2010) 0.96
Photoelectric-enhanced radiation therapy with quasi-monochromatic computed tomography. Med Phys (2009) 0.96
Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys (2003) 0.96
Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys (2010) 0.96
Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res (2005) 0.95
Evaluation of MR-induced hot spots for different temporal SAR modes using a time-dependent finite difference method with explicit temperature gradient treatment. IEEE Trans Biomed Eng (2007) 0.94
Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiat Oncol (2009) 0.94
Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Blood Cells Mol Dis (2005) 0.93
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol (2004) 0.92
CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol (2008) 0.91
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiat Oncol (2010) 0.90
Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol (2013) 0.89
Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours. Eur Radiol (2011) 0.89
Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study. Int J Hyperthermia (2010) 0.89
Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol Imaging Biol (2009) 0.89
Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol (2005) 0.88
[CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases]. Strahlenther Onkol (2004) 0.87
Computed tomography-guided brachytherapy for liver cancer. Semin Radiat Oncol (2011) 0.87
In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiat Res (2009) 0.87
In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys (2005) 0.86
Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes. Radiat Oncol (2011) 0.86
Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T. Magn Reson Med (2005) 0.86
Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol (2008) 0.85
In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (2006) 0.85
CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol (2006) 0.85
Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol (2011) 0.85
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Int J Cancer (2002) 0.84
Local arterial infusion of superparamagnetic iron oxide particles in hepatocellular carcinoma: A feasibility and 3.0 T MRI study. Invest Radiol (2006) 0.84
Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy. BMC Cancer (2006) 0.84
CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest (2005) 0.84
Hyperthermia classic commentary: 'Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia' by Andreas Jordan et al., International Journal of Hyperthermia, 1993;9:51-68. Int J Hyperthermia (2009) 0.83
Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study. Radiother Oncol (2011) 0.83
Imaging-therapy computed tomography with quasi-monochromatic X-rays. Eur J Radiol (2008) 0.83
Radiation exposure to patient and staff in hepatic chemoembolization: risk estimation of cancer and deterministic effects. Cardiovasc Intervent Radiol (2006) 0.83
Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol (2010) 0.83
Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy. Cardiovasc Intervent Radiol (2009) 0.83
Appropriate patient instructions can reduce prostate motion. Radiat Oncol (2012) 0.83
Changes in hepatic blood flow during whole body hyperthermia. Int J Hyperthermia (2010) 0.82
CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization? Eur Radiol (2015) 0.82
[Thermal therapy of prostate cancer using magnetic nanoparticles]. Actas Urol Esp (2007) 0.82
Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol (2012) 0.82
Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series. World J Urol (2012) 0.81
Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degrees C. Eur J Appl Physiol (2005) 0.81
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int J Hyperthermia (2006) 0.81
Perfusion measurement using DCE-MRI: implications for hyperthermia. Int J Hyperthermia (2008) 0.81
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases. Int J Radiat Oncol Biol Phys (2010) 0.81
Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol (2010) 0.81
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy. Strahlenther Onkol (2004) 0.80
Introduction: non-invasive thermometry for thermotherapy. Int J Hyperthermia (2005) 0.80
[Standards and perspectives in locoregional hyperthermia]. Wien Med Wochenschr (2004) 0.80
Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series. Head Face Med (2012) 0.80
Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol (2002) 0.79
Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study. Cardiovasc Intervent Radiol (2014) 0.79
Regularized antenna profile adaptation in online hyperthermia treatment. Med Phys (2010) 0.79
CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma. Strahlenther Onkol (2014) 0.79
A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas. BMC Cancer (2006) 0.78
Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer. Med Dosim (2012) 0.78
In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192Ir high-dose-rate brachytherapy. Radiat Oncol (2011) 0.78
Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology (2003) 0.78